Development of a nationwide genomic screening network for squamous cell lung cancer in Japan (LC-SCRUM-Japan).

被引：0

作者：

Shimokawaji, Tadasuke

Sugiyama, Eri

Matsumoto, Shingo

Yoh, Kiyotaka

Shingyoji, Masato

Ohashi, Kadoaki

Kato, Terufumi

Aono, Hiromi

Ohe, Yuichiro

Sugawara, Shunichi

Furuya, Naoki

Nakazaki, Hirofumi

Taima, Kageaki

Watanabe, Hiroshi

Harada, Taishi

Sakamoto, Tomohiro

Ikemura, Shinnosuke

Tsuchihara, Katsuya

Goto, Koichi

机构：

[1] Yokohama City Univ, Med Ctr, Yokohama, Kanagawa, Japan

[2] Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan

[3] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan

[4] Chiba Canc Ctr, Div Respirol, Chiba, Japan

[5] Okayama Univ Hosp, Dept Resp Med, Okayama, Japan

[6] Kanagawa Cardiovasc & Resp Ctr, Yokohama, Kanagawa, Japan

[7] Mitsui Mem Hosp, Resp Med, Tokyo, Japan

[8] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan

[9] Sendai Kousei Hosp, Sendai, Miyagi, Japan

[10] St Marianna Univ, Sch Med Hosp, Div Resp Med, Kawasaki, Kanagawa, Japan

[11] Matsue Red Cross Hosp, Dept Resp Med, Matsue, Shimane, Japan

[12] Hirosaki Univ Hosp, Hirosaki, Aomori, Japan

[13] Saka Gen Hosp, Shiogama, Japan

[14] Fukuchiyama City Hosp, Dept Med Oncol, Fukuchiyama, Japan

[15] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Translat Res, Chiba, Japan

[16] Keio Univ, Tokyo, Japan

[17] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Translat Res, Kashiwa, Chiba, Japan

[18] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.9097

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9097

引用

页数：3

共 50 条

[21] Development of a Nationwide Genomic Screening Project (SCRUM-Japan) for the Establishment of Cancer Precision Medicine
Goto, Koichi
ANNALS OF ONCOLOGY, 2017, 28 : 19 - 19
[22] The Lung Cancer Genomic Screening Project for Individualized Medicine in Japan (LC-SCRUM-Japan): Screening for RET and ROS1 fusions in advanced EGFR mutation-negative nonsquamous lung cancer and development of molecular targeted therapy.
Yoh, Kiyotaka
Matsumoto, Shingo
Tsuchihara, Katsuya
Kohno, Takashi
Ishii, Genichiro
Tsuta, Koji
Nishio, Makoto
Yamamoto, Noboru
Murakami, Haruyasu
Satouchi, Miyako
Nogami, Naoyuki
Seto, Takashi
Umemura, Shigeki
Niho, Seiji
Ohmatsu, Hironobu
Ohe, Yuichiro
Yamanaka, Takeharu
Goto, Koichi
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[23] Large scale clinico-genomic analyses among patients with BRAF-mutated non-small cell lung cancers (NSCLC) identified by nationwide genomic screening project (LC-SCRUM-Japan).
Sakai, Tetsuya
Matsumoto, Shingo
Nakagawa, Taku
Ohashi, Kadoaki
Itani, Hidetoshi
Shingyoji, Masato
Nakamura, Atsushi
Toyozawa, Ryo
Mori, Masahide
Tuda, Takeshi
Ohe, Yuichiro
Sakamoto, Tomohiro
Kato, Terufumi
Ikeda, Takaya
Zenke, Yoshitaka
Udagawa, Hibiki
Kirita, Keisuke
Yoh, Kiyotaka
Niho, Seiji
Goto, Koichi
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[24] Therapeutic impact of mutation subtypes and concomitant STK11 mutations in KRAS-mutated non-small cell lung cancer (NSCLC): A result of nationwide genomic screening project (LC-SCRUM-Japan).
Tamiya, Yutaro
Zenke, Yochitaka
Matsumoto, Shingo
Furuya, Naoki
Sakamoto, Tomohiro
Kato, Terufumi
Nishino, Kazumi
Shingyoji, Masato
Miyamoto, Shingo
Shirakawa, Chigusa
Toyozawa, Ryo
Ohashi, Kadoaki
Ikeda, Takaya
Nosaki, Kaname
Udagawa, Hibiki
Kirita, Keisuke
Yoh, Kiyotaka
Niho, Seiji
Goto, Koichi
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[25] Phase II study of gedatolisib for small-cell lung cancer (SCLC) patients (pts) with genetic alterations in PI3K/AKT/mTOR pathway based on a large-scale nationwide genomic screening network in Japan (EAGLE-PAT/LC-SCRUM-Japan).
Udagawa, Hibiki
Ikeda, Takaya
Umemura, Shigeki
Daga, Haruko
Toyozawa, Ryo
Harada, Daijiro
Sakakibara-Konishi, Jun
Morise, Masahiro
Yamamoto, Noboru
Takahashi, Toshiaki
Kato, Terufumi
Shingyoji, Masato
Ushio, Ryota
Hara, Satoshi
Takata, Saori
Nomura, Shogo
Matsumoto, Shingo
Niho, Seiji
Sato, Akihiro
Goto, Koichi
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[26] Clinicopathological features of patients with ROS1-rearranged advanced non-small cell lung cancer: LC-SCRUM-Japan
Sugiyama, E.
Matsumoto, S.
Yoh, K.
Ohe, Y.
Seto, T.
Murakami, H.
Iwama, E.
Sugawara, S.
Yamada, K.
Takeda, K.
Hosomi, Y.
Saeki, S.
Yokoyama, T.
Nishio, M.
Satouchi, M.
Tsuta, K.
Kohno, T.
Ishii, G.
Tsuchihara, K.
Goto, K.
EUROPEAN JOURNAL OF CANCER, 2015, 51 : S610 - S610
[27] Immuno-oncology biomarker study in a large cohort of LC-SCRUM-Japan: LC-SCRUM-IBIS
Kunimasa, Kei
Yoh, Kiyotaka
Matsumoto, Shingo
Furuya, Naoki
Miyamoto, Shingo
Oizumi, Satoshi
Tabata, Eriko
Sugawara, Shunichi
Kodani, Masahiro
Okamoto, Norio
Hara, Satoshi
Hayashi, Yuichiro
Motoi, Noriko
Ishii, Genichiro
Goto, Koichi
ANNALS OF ONCOLOGY, 2018, 29
[28] Clinical Outcome of Non-Small Cell Lung Cancer with EGFR/HER2 Exon 20 Insertions Identified in the LC-SCRUM-Japan
Udagawa, H.
Matsumoto, S.
Ohe, Y.
Satouchi, M.
Furuya, N.
Kim, Y. H.
Seto, T.
Soejima, K.
Hayakawa, D.
Kato, T.
Miyamoto, S.
Ohashi, K.
Saeki, S.
Ohta, H.
Fujimoto, D.
Sekine, A.
Yoh, K.
Goto, K.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S224 - S224
[29] The Nationwide Cancer Genome Screening Project in Japan SCRUM-Japan GI-SCREEN
Kawazoe, Akihito
ANNALS OF ONCOLOGY, 2018, 29 : 26 - 26
[30] SCRUM-Japan GI-SCREEN: The nationwide cancer genome screening projects for gastrointestinal cancer in Japan
Yoshino, Takayuki
ANNALS OF ONCOLOGY, 2015, 26 : 5 - 5

← 1 2 3 4 5 →